Report cover image

Cervical Spondylosis Treatment Market, By Type of Treatment (Medications (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Muscle relaxants, Antidepressants and Others) and Surgery), By Route of Administration (Oral, Injection, Topical, and

Publisher Coherent Market Insights
Published Mar 26, 2025
Length 165 Pages
SKU # CMI20008386

Description

Cervical spondylosis is a type of degenerative disease that affects the neck. It is a general term for age-related wear and tear in the cervical spine (neck) that can lead to neck pain, neck stiffness, and other symptoms. Sometimes this condition is called arthritis or osteoarthritis of the neck. It is the natural wearing down of cartilage, disks, ligaments, and bones in the neck. It is very common and worsens with age. In many cases, no specific treatment is required. If symptoms occur, treatments include medication, corticosteroid injections, physiotherapy, and sometimes surgery.

Market Dynamics:

Rising burden of cervical spondylosis, increasing prevalence of neck and back pain, growing geriatric population, and the growing demand for safe & effective cervical spondylosis treatment around the globe are expected to propel the growth of the global cervical spondylosis treatment market.

For instance, cervical spondylosis is a very common cause of myelopathy in the elderly. It is the most common spine dysfunction in elderly people. It is very common and worsens with age. More than 85% of people older than the age of 60 are affected by cervical spondylosis. Thus, with the growing geriatric population and the rising burden of cervical spondylosis, the demand for safe and effective cervical spondylosis treatment is also increasing. As per the World Health Organization (WHO), by 2030, one in six people in the world will be aged 60 years or over, and the world’s population of people aged 60 years and older will double (2.1 billion) by 2050.

Key Features of the Study:
  • This report provides an in-depth analysis of the global cervical spondylosis treatment market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cervical spondylosis treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Pfizer Inc., Abbott Laboratories, AstraZeneca Plc., Novartis AG, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Sanofi S.A., Stryker Corporation, Zimmer Biomet Holdings, Inc., and Medtronic plc
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global cervical spondylosis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cervical spondylosis treatment market
Detailed Segmentation:
  • By Type of Treatment:
  • Medication
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Corticosteroids
  • Muscle relaxants
  • Antidepressants
  • Others (Anti-seizure medications, etc.)
  • Surgery
  • By Route of Administration:
  • Oral
  • Injection
  • Topical
  • Others (patches, etc.)
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
  • Company Profiles:
  • Pfizer Inc.
  • Abbott Laboratories
  • AstraZeneca Plc.
  • Novartis AG
  • Merck & Co. Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Sanofi S.A.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Medtronic plc

Table of Contents

165 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Cervical Spondylosis Treatment Market, By Type of Treatment
Global Cervical Spondylosis Treatment Market, By Route of Administration
Global Cervical Spondylosis Treatment Market, By Distribution Channel
Global Cervical Spondylosis Treatment Market, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Cervical Spondylosis Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Cervical Spondylosis Treatment Market, By Type of Treatment, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Medication
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Muscle relaxants
Antidepressants
Others
Surgery
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
6. Cervical Spondylosis Treatment Market, By Route of Administration, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Injection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
7. Cervical Spondylosis Treatment Market, By Distribution Channel, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
8. Cervical Spondylosis Treatment Market, By Region, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Abbott Laboratories
AstraZeneca Plc.
Novartis AG
Merck & Co. Inc.
Teva Pharmaceutical Industries Ltd.
Amgen Inc.
Bristol-Myers Squibb Company
Eli Lilly and Company
GlaxoSmithKline plc
Johnson & Johnson Services, Inc.
Sanofi S.A.
Stryker Corporation
Zimmer Biomet Holdings, Inc.
Medtronic plc
10. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on Global Cervical Spondylosis Treatment Market” - Global forecast to 2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us